Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AFFIRM is a nitric oxide-boosting nutraceutical developed by Dr. Judson Brandeis and marketed through AFFIRM Science and Brandeis MD. It is specifically formulated to support erectile function and cardiovascular health by enhancing the nitric oxide pathway. The supplement contains a combination of pharmaceutical-grade active ingredients, including L-citrulline, red beet root extract, Panax ginseng, and Muira puama. By increasing nitric oxide production, AFFIRM promotes vasodilation and improves blood flow to penile tissues. Clinical research, including the CONfirm studies, has demonstrated that the supplement can increase the intensity and duration of nighttime erectile activity by approximately 33% in men with mild erectile dysfunction. It is frequently used as an adjunct to shockwave therapy for erectile dysfunction and is also indicated for improving energy and athletic performance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AFFIRM.